Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 550

1.

Definitive and sustained increase in prostate cancer metastases in the United States.

Patel NA, Sedrakyan A, Bianco F, Etzioni R, Gorin MA, Hsu WC, Mao J, Nguyen PL, Schaeffer E, Shoag J, Vickers A, Hu JC.

Urol Oncol. 2019 Sep 12. pii: S1078-1439(19)30320-5. doi: 10.1016/j.urolonc.2019.08.002. [Epub ahead of print]

PMID:
31522862
2.

Re: A Population-Based Cohort Study of the Impact of Infectious Complications Requiring Hospitalization after Prostate Biopsy on Radical Prostatectomy Surgical Outcomes.

Schaeffer EM.

J Urol. 2019 Sep 13:101097JU0000000000000551. doi: 10.1097/JU.0000000000000551. [Epub ahead of print] No abstract available.

PMID:
31518190
3.

Re: Incidence and Microbiology of Post-Operative Infections after Radical Cystectomy and Ureteral Stent Removal; A Retrospective Cohort Study.

Schaeffer EM.

J Urol. 2019 Sep 13:10109701JU00005852206810294. doi: 10.1097/01.JU.0000585220.68102.94. [Epub ahead of print] No abstract available.

PMID:
31518186
4.

Transcriptomic heterogeneity of androgen receptor (AR) activity defines a de novo low AR-active subclass in treatment naïve primary prostate cancer.

Spratt DE, Alshalalfa M, Fishbane N, Weiner AB, Mehra R, Mahal BA, Lehrer J, Liu Y, Zhao SG, Speers C, Morgan TM, Dicker AP, Freedland SJ, Karnes RJ, Weinmann S, Davicioni E, Ross AE, Den RB, Nguyen PL, Feng FY, Lotan TL, Chinnaiyan AM, Schaeffer EM.

Clin Cancer Res. 2019 Sep 12. pii: clincanres.1587.2019. doi: 10.1158/1078-0432.CCR-19-1587. [Epub ahead of print]

PMID:
31515456
5.

Ultrasound Characteristics of Clinically Dislocated But Reducible Hips With DDH.

Striano B, Schaeffer EK, Matheney TH, Upasani VV, Price CT, Mulpuri K, Sankar WN; International Hip Dysplasia Institute.

J Pediatr Orthop. 2019 Oct;39(9):453-457. doi: 10.1097/BPO.0000000000001048.

PMID:
31503230
6.

Analysis of the medical response to November 2015 Paris terrorist attacks: resource utilization according to the cause of injury.

Raux M, Carli P, Lapostolle F, Langlois M, Yordanov Y, Féral-Pierssens AL, Woloch A, Ogereau C, Gayat E, Attias A, Pateron D, Castier Y, François A, Ludes B, Dolla E, Tourtier JP, Riou B; TRAUMABASE Group.

Intensive Care Med. 2019 Sep;45(9):1231-1240. doi: 10.1007/s00134-019-05724-9. Epub 2019 Aug 15.

PMID:
31418059
7.

Validation of the Decipher Test for Predicting Distant Metastatic Recurrence in Men with High-risk Nonmetastatic Prostate Cancer 10 Years After Surgery.

Van den Broeck T, Moris L, Gevaert T, Tosco L, Smeets E, Fishbane N, Liu Y, Helsen C, Margrave J, Buerki C, Davicioni E, Van Poppel H, Everaerts W, Weinmann S, Den R, Davis J, Schaeffer E, Karnes RJ, Claessens F, Joniau S.

Eur Urol Oncol. 2019 Sep;2(5):589-596. doi: 10.1016/j.euo.2018.12.007. Epub 2019 Jan 11.

PMID:
31411980
8.

Re: Reduced Recurrence of Low-Grade Papillary Bladder Tumors Associated with Asymptomatic Bacteriuria.

Schaeffer EM.

J Urol. 2019 Aug 6:101097JU0000000000000485. doi: 10.1097/JU.0000000000000485. [Epub ahead of print] No abstract available.

PMID:
31385735
9.

Corrigendum to: National practice patterns for lymph node irradiation in 197,000 men receiving external beam radiotherapy for localized prostate cancer.

Weiner AB, Ko OS, Zhu A, Spratt DE, Hu JC, Schaeffer EM.

Urol Oncol. 2019 Aug;37(8):563. doi: 10.1016/j.urolonc.2019.07.003. No abstract available.

PMID:
31351589
10.

Effects of Exergaming on Attentional Deficits and Dual-Tasking in Parkinson's Disease.

Schaeffer E, Busch JH, Roeben B, Otterbein S, Saraykin P, Leks E, Liepelt-Scarfone I, Synofzik M, Elshehabi M, Maetzler W, Hansen C, Andris S, Berg D.

Front Neurol. 2019 Jun 19;10:646. doi: 10.3389/fneur.2019.00646. eCollection 2019.

11.

Re: Ibuprofen versus Pivmecillinam for Uncomplicated Urinary Tract Infection in Women-A Double-Blind, Randomized Non-Inferiority Trial.

Schaeffer EM.

J Urol. 2019 Jul 4:101097JU0000000000000432. doi: 10.1097/JU.0000000000000432. [Epub ahead of print] No abstract available.

PMID:
31271546
12.

Re: Once-Daily Plazomicin for Complicated Urinary Tract Infections.

Schaeffer EM.

J Urol. 2019 Jul 4:10109701JU0000576820062388b. doi: 10.1097/01.JU.0000576820.06238.8b. [Epub ahead of print] No abstract available.

PMID:
31271545
13.

DNA-Dependent Protein Kinase Drives Prostate Cancer Progression through Transcriptional Regulation of the Wnt Signaling Pathway.

Kothari V, Goodwin JF, Zhao SG, Drake JM, Yin Y, Chang SL, Evans JR, Wilder-Romans K, Gabbara K, Dylgjeri E, Chou J, Sun G, Tomlins SA, Mehra R, Hege K, Filvaroff EH, Schaeffer EM, Karnes RJ, Quigley DA, Rathkopf DE, He HH, Speers C, Spratt DE, Gilbert LA, Ashworth A, Chinnaiyan AM, Raj GV, Knudsen KE, Feng FY.

Clin Cancer Res. 2019 Sep 15;25(18):5608-5622. doi: 10.1158/1078-0432.CCR-18-2387. Epub 2019 Jul 2.

PMID:
31266829
14.

Re: Association of Screening and Treatment for Preoperative Asymptomatic Bacteriuria with Postoperative Outcomes among US Veterans.

Schaeffer EM.

J Urol. 2019 Sep;202(3):441. doi: 10.1097/JU.0000000000000370. Epub 2019 Aug 8. No abstract available.

PMID:
31169452
15.

Transcriptomic and Clinical Characterization of Neuropeptide Y Expression in Localized and Metastatic Prostate Cancer: Identification of Novel Prostate Cancer Subtype with Clinical Implications.

Alshalalfa M, Nguyen PL, Beltran H, Chen WS, Davicioni E, Zhao SG, Rebbeck TR, Schaeffer EM, Lotan TL, Feng FY, Mahal BA.

Eur Urol Oncol. 2019 Jul;2(4):405-412. doi: 10.1016/j.euo.2019.05.001. Epub 2019 Jun 2.

PMID:
31164324
16.

Characterization of transcriptomic signature of primary prostate cancer analogous to prostatic small cell neuroendocrine carcinoma.

Alshalalfa M, Liu Y, Wyatt AW, Gibb EA, Tsai HK, Erho N, Lehrer J, Takhar M, Ramnarine VR, Collins CC, Den RB, Schaeffer EM, Davicioni E, Lotan TL, Bismar TA.

Int J Cancer. 2019 May 24. doi: 10.1002/ijc.32430. [Epub ahead of print]

PMID:
31125117
17.

Association of Black Race With Prostate Cancer-Specific and Other-Cause Mortality.

Dess RT, Hartman HE, Mahal BA, Soni PD, Jackson WC, Cooperberg MR, Amling CL, Aronson WJ, Kane CJ, Terris MK, Zumsteg ZS, Butler S, Osborne JR, Morgan TM, Mehra R, Salami SS, Kishan AU, Wang C, Schaeffer EM, Roach M 3rd, Pisansky TM, Shipley WU, Freedland SJ, Sandler HM, Halabi S, Feng FY, Dignam JJ, Nguyen PL, Schipper MJ, Spratt DE.

JAMA Oncol. 2019 Jul 1;5(7):975-983. doi: 10.1001/jamaoncol.2019.0826.

18.

African American Specific Gene Panel Predictive of Poor Prostate Cancer Outcome.

Echevarria MI, Awasthi S, Cheng CH, Berglund AE, Rounbehler RJ, Gerke TA, Takhar M, Davicioni E, Klein EA, Freedland SJ, Ross AE, Schaeffer EM, Den RB, Cleveland JL, Park JY, Rayford W, Yamoah K.

J Urol. 2019 Aug;202(2):247-255. doi: 10.1097/JU.0000000000000193. Epub 2019 Jul 8.

PMID:
31107158
19.

Prostate cancer in sexual minorities and the influence of HIV status.

Amarasekera C, Wong V, Yura E, Manjunath A, Schaeffer E, Kundu S.

Nat Rev Urol. 2019 Jul;16(7):404-421. doi: 10.1038/s41585-019-0194-2. Review.

PMID:
31101896
20.

Oligometastatic Prostate Cancer: A Shrinking Subset or an Opportunity for Cure?

Rao A, Vapiwala N, Schaeffer EM, Ryan CJ.

Am Soc Clin Oncol Educ Book. 2019 Jan;39:309-320. doi: 10.1200/EDBK_239041. Epub 2019 May 17.

PMID:
31099652

Supplemental Content

Loading ...
Support Center